Search clinical trials for: Baricitinib 4 milligram Oral Tablet

Total 2211 results

University of North Carolina, Chapel Hill
Eli Lilly and Company

Recruiting

Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study

Lichen Planus, Oral | Oral Lichen Planus | Lichen Planus, Mucosal

United States
University of Alabama at Birmingham
Eli Lilly and Company

Not yet recruiting

A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)

Frontal Fibrosing Alopecia

United States
Azienda Ospedaliero, Universitaria Pisana

Unknown

Baricitinib Compared to Standard Therapy in Patients With COVID-19 (BARICIVID-19)

Covid-19 | SARS-CoV 2 | SARS Pneumonia

Italy
Assistance Publique - Hôpitaux de Paris

Terminated

BARIcitinib Cognitive Emotional and Neural signaTuRE (BARICENTRE)

Rheumatoid Arthritis

France
William Tyor
National Institute of Mental Health (NIMH)

Recruiting

Baricitinib for Reduction of HIV - CNS

Human Immunodeficiency Virus

United States
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Completed

Efficacy and Safety of Baricitinib for the Treatment of Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Bangladesh
Eli Lilly and Company

Completed

A Study of Baricitinib in Healthy Participants

Healthy

Singapore
University of California, Los Angeles

Recruiting

Metformin Treatment in Progressive Multiple Sclerosis

Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis

United States
Aaron R. Mangold

Completed

Baricitinib (LY3009104) in the Treatment of Cutaneous Lichen Planus

Cutaneous Lichen Planus

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...
Radboud University Medical Center; Universitaire Ziekenhuizen KU Leuven; University... and other collaborators

Recruiting

Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose (PEARL)

Liver Diseases | Hepatic Encephalopathy | Portal Hypertension | Cirrhosis, Liver | Pathological Processes

Netherlands, Belgium
Harmony Biosciences, LLC

Active, not recruiting

A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension

Prader-Willi Syndrome

United States
Vaxart

Completed

Safety & Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines (VXA-NVV-103)

Norovirus Infection

United States
Valenta Pharm JSC

Recruiting

Safety, Tolerability and Pharmacokinetics of 4-MUST, Tablets, 128 mg (Valenta Pharm JSC) During Single and Multiple Oral Administration in Healthy Volunteers

Cholecystitis

Russian Federation
Vanderbilt University Medical Center
Yale University; Emory University; University of California, San Francisco; Vanderbilt... and other collaborators

Not yet recruiting

REVERSE-Long COVID-19 With Baricitinib Study (REVERSE-LC)

Post-Acute COVID-19 Syndrome

United States
University Hospital, Bordeaux

Completed

Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo (BARVIT)

Vitiligo

France
University of Nottingham
Sanofi

Recruiting

MRI Assessment of Mode of Action of Bisacodyl, Multiple Doses (MODEM)

Constipation

United Kingdom
Tang-Du Hospital

Not yet recruiting

Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions

Traumatic Brain Injury

China
University Medical Centre Ljubljana

Recruiting

Duration of Doxycycline Treatment in MEM Patients

Erythema Chronicum Migrans

Slovenia
Fulcrum Therapeutics

Completed

Relative Bioavailability and Food Effect Study of Losmapimod 15 mg Tablets

Healthy Adult Subjects

United States
Alexandria University
University of Alexandria

Completed

Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy

Helicobacter Pylori Infection

Egypt
Dong Wha Pharmaceutical Co. Ltd.

Completed

The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male Volunteer

Diabetic Kidney Disease

Korea, Republic of
Paratek Pharmaceuticals Inc

Active, not recruiting

Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)

Mycobacterium Infections, Nontuberculous | Nontuberculous Mycobacterial Lung Disease | Mycobacterium Abscessus Infection | Nontuberculous Mycobacterial Pulmonary Infection

United States
Stanford University
Mayo Clinic; University of British Columbia; Albert Einstein College of Medicine and other collaborators

Completed

Pain Control Following Sinus Surgery

Pain | Postoperative Pain | Sinusitis | Opioid Use | Opioid Abuse | Narcotic Use | Otolaryngologic Disease

United States, Canada
University of Nottingham
Sanofi

Recruiting

MRI Assessment of Mode of Action of Bisacodyl, Single Dose (MODS)

Constipation

United Kingdom
Rigshospitalet, Denmark

Completed

The Association Between Hyponatremia and Osteoporosis in Patients With Epilepsy.

Hyponatremia | Metabolic Bone Disease

Denmark
University Hospital, Rouen

Not yet recruiting

Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis (JAKUVEITE)

Active Non-anterior Non-infectious Uveitis
National Institute of Diabetes and Digestive and...
Pfizer

Recruiting

Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)

Diabetes Mellitus, Type 1

United States
Prof. Dr. Matthias Preusser

Completed

A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic

COVID

Austria
Chinese University of Hong Kong

Recruiting

Effect of JAK Inhibitor on Erosion Healing in RA

Rheumatoid Arthritis

Hong Kong
Fundacion Clinic per a la Recerca Biomédica

Unknown

Efficacy and Tolerance of 4 Weeks of Tedizolid in Prosthetic Joint Infections Treated With Implant Removal (PROTEDI)

Prostheses Infection
Hospital Universitario de Fuenlabrada
Centro Nacional de Investigaciones Oncologicas CARLOS III

Active, not recruiting

Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 (Covid19COVINIB)

COVID-19 Pneumonia

Spain
University of Cincinnati
Procter and Gamble

Completed

Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol) (SABER-C)

COVID-19 | Diarrhea

United States
Assiut University

Recruiting

Use of Baricitenib to Maintain of Remission

Nephritis | Lupus or SLE

Egypt
Nantes University Hospital

Not yet recruiting

"Baricitinib for Treating Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype. (TREAT-HAP)

Hospital-acquired Pneumonia

France, Spain, Netherlands, Belgium
Zydus Therapeutics Inc.

Completed

Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis (EPICS)

Primary Biliary Cirrhosis

United States
Samar Atef Sebaweh Mohammed

Completed

Rifaximin Prophylaxis for Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome in Cirrhotic Patients

Ascites Infection

Egypt
Estetra
ICON Clinical Research

Completed

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort)

Vasomotor Symptoms | Menopausal Symptoms

United States, Canada
Wake Forest University Health Sciences

Completed

Opioid Free Management After Ureteroscopy

Kidney Stone

United States
Fabrizio Cantini

Completed

Baricitinib Therapy in COVID-19

Pneumonia | COVID

Italy
Maastricht University
Netherlands Brain Foundation

Completed

Roflumilast to Treat Cognitive Sequela After Stroke (ROSTMEMA)

Cerebrovascular Disorders | Functional Recovery | Memory | Drug Intervention

Netherlands
GlaxoSmithKline

Completed

Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease

Liver Diseases

Japan
EicOsis Human Health Inc.

Recruiting

Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Oral EC5026 in Healthy Subjects

Healthy Subjects

New Zealand
Cara Therapeutics, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Chronic Kidney Diseases | Pruritus

United States
Harmony Biosciences, LLC

Active, not recruiting

Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1

Myotonic Dystrophy 1 | Excessive Daytime Sleepiness

United States, Canada
Syntrix Biosystems, Inc.
National Institute on Drug Abuse (NIDA); DF/Net Research

Completed

Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy

Diabetic Neuropathies | Neuropathic Pain | Pain, Chronic

United States
Vaxart

Completed

Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine

Norovirus Gastroenteritis

United States
Fulcrum Therapeutics

Terminated

Losmapimod Safety and Efficacy in COVID-19 (LOSVID)

COVID-19

United States, Mexico, Brazil, Peru
EicOsis Human Health Inc.

Completed

Safety, Tolerability, Pharmacokinetics and Food Effects of Oral EC5026 in Healthy Subjects

Healthy Adults

United States
University of Michigan

Completed

Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 (DICER)

Covid-19 | COVID | Corona Virus Infection | SARS-CoV-2 Infection

United States
Damanhour University

Completed

Ivabradine in Patients With Congestive Heart Failure

Congestive Heart Failure

Egypt

Search clinical trials for: Baricitinib 4 milligram Oral Tablet

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations